Hi
@Jamie S,
I'm a type 1 diabetic currently on a Levemir split dose and I'll be switching to a new basal insulin once I've seen my diabetes consultant in July next year. My last appointment with my diabetes consultant was in July this year and I mentioned the Levemir discontinuation at the time. Interestingly, my consultant did not bring it up. I had to bring it up with them!
At that time, my diabetes consultant was unable to switch me over to a new basal insulin due to restrictions that were in place regarding switching. These restrictions are no longer in place but I won't be seeing my diabetes consultant again until next year so I won't be able to switch over to a new basal insulin until then.
When I asked my diabetes consultant about the possible options regarding the switch, I was advised to look into Tresiba and Toujeo. I wasn't offered any other choices.
I've been using Levemir for over 16 years and my split dose is very uneven (a large amount in the morning and just a unit or two before bed). I have good blood glucose control with it so I'm apprehensive about the switch.
Prior to going on Levemir, I was on Lantus (a glargine insulin) and based on that experience, I wouldn't want to use a glargine insulin again. On Lantus, I experienced quite sudden and dramatic lows as well as redness, stinging, burning and swelling around my injection sites (I think due to the acidity of the glargine insulin). I note that Toujeo is also a glargine insulin. Therefore, it seems my only real option is Tresiba.
I'm currently using NovoRapid as my bolus and this insulin has worked well for me for many years. I believe I'll be staying on NovoRapid and just changing the basal insulin only.